Literature DB >> 16954164

Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans.

Deborah J Wake1, Natalie Z M Homer, Ruth Andrew, Brian R Walker.   

Abstract

CONTEXT: Extraadrenal regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 (11HSD1) is increased after a mixed meal. It is unknown which tissue is responsible and whether this reflects the complex transcriptional control of 11HSD1 or posttranscriptional control exerted by supply of reduced nicotinamide adenine dinucleotide phosphate from hexose-6-phosphate dehydrogenase.
OBJECTIVE: The objective of this study was to test whether hyperinsulinemia and/or increased serum free fatty acids increase whole-body and intraadipose 11HSD1, and whether adipose 11HSD1 switches from dehydrogenase to reductase activity.
METHODS: In nine healthy men, we measured whole-body cortisol regeneration (by iv infusion of 9,11,12,12-[2H]4 -cortisol) and intra-adipose interconversion of cortisol and cortisone (by sc microdialysis infusion of [3H]4 -cortisol and [3H]2 -cortisone in separate cannulae) during: 1) a hyperinsulinemic euglycemic clamp; 2) iv lipid infusion (Intralipid 20% fat emulsion); and 3) saline infusion, each for 3.5 h.
RESULTS: Hyperinsulinemia increased rate of appearance of 9,12,12-[2H]3 -cortisol (19.3 +/- 0.8 vs. 16.7 +/- 1.1 nmol/min with saline, P < 0.001), indicating increased whole-body 11HSD1. Within adipose, the predominant reaction was reductase conversion of cortisone to cortisol (after 3.5 h of saline infusion, reaching 11.0 +/- 2.7% per hour reductase vs. 5.2 +/- 1.3 dehydrogenase, P < 0.02); insulin increased reductase (reaching 15.8 +/- 3.0, P < 0.05) and tended to increase dehydrogenase activity. Intralipid infusion had no effects on whole-body deuterated cortisol metabolism, but increased both dehydrogenase and reductase (reaching 16.7 +/- 1.8, P < 0.01) activities in adipose.
CONCLUSIONS: Hyperinsulinemia and increased free fatty acids induce acute increases in 11HSD1 activity in adipose tissue that are not attributable to a switch from dehydrogenase to reductase. Hyperinsulinemia also increases systemic cortisol regeneration. These effects may enhance intracellular cortisol concentrations after a meal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954164     DOI: 10.1210/jc.2006-0819

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice.

Authors:  Abudukadier Abulizi; João-Paulo Camporez; Dongyan Zhang; Varman T Samuel; Gerald I Shulman; Daniel F Vatner
Journal:  Metabolism       Date:  2018-12-19       Impact factor: 8.694

2.  Glucocorticoids turn over slowly in human adipose tissue in vivo.

Authors:  Katherine A Hughes; Rebecca M Reynolds; Ruth Andrew; Hilary O D Critchley; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

3.  Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.

Authors:  Mi-Jeong Lee; Susan K Fried; Steven S Mundt; Yanxin Wang; Sean Sullivan; Alice Stefanni; Bruce L Daugherty; Anne Hermanowski-Vosatka
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

4.  Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.

Authors:  Simmi Dube; Michael Q Slama; Ananda Basu; Robert A Rizza; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2015-08-26       Impact factor: 5.958

5.  Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Aran Balachandran; Haiyan Guan; Michael Sellan; Stan van Uum; Kaiping Yang
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

Review 6.  Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease.

Authors:  Mousumi Bose; Blanca Oliván; Blandine Laferrère
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-10       Impact factor: 3.243

7.  11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.

Authors:  Simmi Dube; Barbara J Norby; Vishwanath Pattan; Rickey E Carter; Ananda Basu; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

8.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

Authors:  Jeremy W Tomlinson; Mark Sherlock; Beverley Hughes; Susan V Hughes; Fiona Kilvington; William Bartlett; Rachel Courtney; Paul Rejto; William Carley; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

Review 9.  Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

Authors:  Andreas Stomby; Ruth Andrew; Brian R Walker; Tommy Olsson
Journal:  Diabetologia       Date:  2014-04-08       Impact factor: 10.122

10.  Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Moffat J Nyirenda; Roderick Carter; Justin I Tang; Annick de Vries; Christina Schlumbohm; Stephen G Hillier; Frank Streit; Michael Oellerich; Victor W Armstrong; Eberhard Fuchs; Jonathan R Seckl
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.